Antimicrobial effects of niridazole on gardnerella vaginalis
- 1 March 1987
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 15 (2) , 128
- https://doi.org/10.1007/bf01650215
Abstract
Niridazole, a nitrothiazole derivative, demonstrated powerful antimicrobial activity against 510 clinical isolates ofGardnerella vaginalis tested. MIC's ranged from 0.002 to 1.0 mg/l with MIC50 and MIC90 values of 0.02 and 0.067 mg/l, respectively. Niridazol, ein Nitrothiazol-Derivat, wies bei der Testung von 510 klinischen Isolaten vonGardnerella vaginalis hohe antimikrobielle Wirksamkeit gegen diesen Erreger auf. Die MHK-Werte waren im Bereich von 0,002 bis 1,0 mg/l; die MHK50 lag bei 0,02 mg/l, die MHK90 bei 0,067 mg/l.This publication has 7 references indexed in Scilit:
- Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coliAntimicrobial Agents and Chemotherapy, 1984
- Antibacterial effects of niridazole: Its effect on microaerophilic campylobacterInfection, 1984
- In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazoleAntimicrobial Agents and Chemotherapy, 1984
- Minimal criteria for the identification of Gardnerella vaginalis isolated from the vagina.Journal of Clinical Pathology, 1983
- Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteriaAntimicrobial Agents and Chemotherapy, 1982
- GARDNERELLA VAGINALIS, ANAEROBES, AND VAGINAL DISCHARGEThe Lancet, 1982
- Inhibition of Corynebacterium vaginale by MetronidazoleSexually Transmitted Diseases, 1977